José Ramón González‐Juanatey
Inserm
3 papers in the Anchorcite directory, published between 2016 and 2021, cited 16,711 times in total.
ORCID profileResearch topics
- Heart Failure Treatment and Management · 3 papers
- Cardiovascular Function and Risk Factors · 2 papers
- Diabetes Treatment and Management · 2 papers
- Clinical practice guidelines implementation · 1 paper
- Chronic Kidney Disease and Diabetes · 1 paper
Frequent co-authors
- Piotr P. Ponikowski · 3 papers
- Stefan D. Anker · 3 papers
- Milton Packer · 2 papers
- Javed Butler · 2 papers
- Gerasimos S Filippatos · 2 papers
- Stuart Pocock · 2 papers
- Peter E. Carson · 2 papers
- James L. Januzzi · 2 papers
Papers
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart FailureEuropean Journal of Heart Failure · 2016 · 6,032 citations
... Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition,…
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureNew England Journal of Medicine · 2020 · 5,468 citations
BACKGROUNDSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.More evidence is needed regarding the effects of these drugs in patients across the broad spectrum of heart…
- Empagliflozin in Heart Failure with a Preserved Ejection FractionNew England Journal of Medicine · 2021 · 5,211 citations
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain. METHODS: In…
Metadata from OpenAlex (CC0).